Assay of the human liver citric acid cycle probe phenylacetylglutamine and of phenylacetate in plasma by gas chromatography-mass spectrometry - PubMed (original) (raw)
Assay of the human liver citric acid cycle probe phenylacetylglutamine and of phenylacetate in plasma by gas chromatography-mass spectrometry
D Yang et al. Anal Biochem. 1993 Jul.
Abstract
Phenylacetate, derived from phenylalanine, is converted in human and primate liver to phenylacetylglutamine. The latter has been used to assess the labeling pattern of liver citric acid cycle intermediates. We present gas chromatographic-mass spectrometric assays of phenylacetylglutamine, phenylacetate, and phenylalanine in biological fluids. The compounds are derivatized with dimethylformamide dimethyl acetal. Limits of detection are 0.1 nmol for phenylacetylglutamine and phenylacetate and 2 nmol for phenylalanine. Baseline plasma concentrations of phenylacetate and phenylacetylglutamine and 1 and 3 microM, respectively. The 24-h urinary excretions of phenylacetate and phenylacetylglutamine are about 4 mumol and 1 mmol, respectively. Ingestion of phenylalanine (in the form of aspartame) by a human is followed by sequential increases in phenylacetate and phenylacetylglutamine concentrations in plasma and urine. This assay opens the way to noninvasive probing of the 13C-labeling pattern of liver citric acid cycle intermediates in humans.
Similar articles
- Assay of the concentration and 13C-labeling pattern of phenylacetylglutamine by nuclear magnetic resonance.
Dugelay S, Yang D, Soloviev MV, Previs SF, Agarwal KC, Fernandez CA, Brunengraber H. Dugelay S, et al. Anal Biochem. 1994 Sep;221(2):368-73. doi: 10.1006/abio.1994.1427. Anal Biochem. 1994. PMID: 7810879 - Noninvasive probing of citric acid cycle intermediates in primate liver with phenylacetylglutamine.
Yang D, Previs SF, Fernandez CA, Dugelay S, Soloviev MV, Hazey JW, Agarwal KC, Levine WC, David F, Rinaldo P, Beylot M, Brunengraber H. Yang D, et al. Am J Physiol. 1996 May;270(5 Pt 1):E882-9. doi: 10.1152/ajpendo.1996.270.5.E882. Am J Physiol. 1996. PMID: 8967478 - Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Jiang Y, Almannai M, Sutton VR, Sun Q, Elsea SH. Jiang Y, et al. Mol Genet Metab. 2017 Nov;122(3):39-45. doi: 10.1016/j.ymgme.2017.08.011. Epub 2017 Aug 31. Mol Genet Metab. 2017. PMID: 28888854 - Glutamate, a window on liver intermediary metabolism.
Yang D, Brunengraber H. Yang D, et al. J Nutr. 2000 Apr;130(4S Suppl):991S-4S. doi: 10.1093/jn/130.4.991S. J Nutr. 2000. PMID: 10736368 Review. - Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases.
Krishnamoorthy NK, Kalyan M, Hediyal TA, Anand N, Kendaganna PH, Pendyala G, Yelamanchili SV, Yang J, Chidambaram SB, Sakharkar MK, Mahalakshmi AM. Krishnamoorthy NK, et al. ACS Omega. 2024 Jan 8;9(3):3164-3172. doi: 10.1021/acsomega.3c08184. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284070 Free PMC article. Review.
Cited by
- Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J, Chen Y, Zhang R, He J, Song Y, Wang J, Wang H, Wang L, Zhan Q, Abliz Z. Xu J, et al. Sci Rep. 2016 Oct 11;6:35010. doi: 10.1038/srep35010. Sci Rep. 2016. PMID: 27725730 Free PMC article. - Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.
Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T. Itoh Y, et al. Mass Spectrom (Tokyo). 2013;2(Spec Iss):S0017. doi: 10.5702/massspectrometry.S0017. Epub 2013 Apr 15. Mass Spectrom (Tokyo). 2013. PMID: 24349936 Free PMC article. - Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study.
Wijeyesekera A, Clarke PA, Bictash M, Brown IJ, Fidock M, Ryckmans T, Yap IK, Chan Q, Stamler J, Elliott P, Holmes E, Nicholson JK. Wijeyesekera A, et al. Anal Methods. 2012 Jan 1;4(1):65-72. doi: 10.1039/C1AY05427A. Anal Methods. 2012. PMID: 23946767 Free PMC article. - Parallel labeling experiments and metabolic flux analysis: Past, present and future methodologies.
Crown SB, Antoniewicz MR. Crown SB, et al. Metab Eng. 2013 Mar;16:21-32. doi: 10.1016/j.ymben.2012.11.010. Epub 2012 Dec 14. Metab Eng. 2013. PMID: 23246523 Free PMC article. Review. - Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.
Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Ramezani A, et al. Am J Kidney Dis. 2016 Mar;67(3):483-98. doi: 10.1053/j.ajkd.2015.09.027. Epub 2015 Nov 15. Am J Kidney Dis. 2016. PMID: 26590448 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources